SG

Healthcare · Pharmaceuticals

Shree Ganesh Remedies Ltd (SGRL)

₹605.75

Mkt cap
₹778 Cr
P/E ratio
64.20
P/B
4.70
Div yield
0.00%
ROE
10.80%
ROCE
14.20%
EPS (TTM)
₹9.44
Book value
₹129
52W range
477–750
Sector
Healthcare

Price history

Previous close

Shree Ganesh Remedies is an Ankleshwar-based manufacturer of pharmaceutical/API intermediates and specialty and fine chemicals. It also provides custom synthesis and contract manufacturing for pharmaceutical, agrochemical, polymer, and electronics customers across more than 20 countries. [1] [2]

NSE SGRLBSE 540737
Health check
Mixed
ValuationExpensive
ProfitabilityAverage
GrowthHigh
TechnicalsNeutral
52-week range
−19.22% from high
₹606
₹477+26.98% from low₹750
Current
₹605.75
Prev close
₹616.05
Day
−1.67%
Price performance
1D
−1.75%
1W
−8.01%
1M
−7.57%
3M
+20.80%
6M
—
1Y
—
YTD
+12.80%

Financials

Revenue, profit & margin
P/E ratio
64.2×
SGRL is 98% above the sector median of 32.5×
SGRL64.2×
Sector median32.5×
 Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026Trend
Sales33.4227.9737.3324.7832.3327.0524.4324.6730.3221.1133.2014.3623.29
YoY Sales growth+57.20%+27.19%+26.07%-7.26%-3.26%-3.29%-34.56%-0.44%-6.22%-21.96%+35.90%-41.79%-23.19%
Expenses24.1919.7620.3916.6521.0217.1414.5517.3720.7014.3821.8211.0119.35
Operating Profit9.238.2116.948.1311.319.919.887.309.626.7311.383.353.94
OPM %27.62%29.35%45.38%32.81%34.98%36.64%40.44%29.59%31.73%31.88%34.28%23.33%16.92%
Other Income0.801.111.320.540.190.712.290.660.690.661.020.941.41
Interest0.010.020.150.320.430.380.960.941.010.740.880.320.58
Depreciation1.411.881.862.022.422.702.422.422.592.672.802.442.50
Profit before tax8.617.4216.256.338.657.548.794.606.713.988.721.532.27
Tax %23.81%35.31%22.46%26.70%25.78%27.85%24.80%25.00%26.23%22.36%28.10%27.45%27.75%
Net Profit6.554.8012.594.656.425.436.603.454.963.106.271.121.63
EPS in Rs5.413.9710.403.625.004.235.142.693.862.414.880.871.27
Raw PDF

Earnings

Results dates & reactions
No upcoming results date on calendar.

Fresh quarters land in the Financials table above, tagged NSE until screener catches up.

No reaction history yet.
No quarterly filings ingested yet.

Corporate actions

Last 6 months

No recent corporate actions

Dividends, splits, and bonuses in the last six months show up here.

Shareholding

as of Sep 2026
72.83%Promoter
Promoters72.83%
FIIs0.00%
DIIs0.99%0.47
Public26.17%0.48
Ownership trend

Peers

8 companies
Valuation vs quality
P/E × ROCE · bubble = market cap
NameCMPP/EMkt CapDiv YldNP QtrQtr Profit VarSales QtrQtr Sales VarROCE
Sun Pharma.Inds.₹1,884.9036.764,52,2510.85%1,995−10.53%16,199+11.88%20.53%
Divi's Lab.₹11,180.5086.862,96,8070.27%1,127+63.57%3,676+35.40%21.97%
Torrent Pharma.₹4,689.5082.161,78,3740.81%534−10.03%4,979+50.79%15.19%
Laurus Labs₹2,294.6092.531,23,9800.09%436+126.43%2,206+33.44%17.76%
Zydus Lifesci.₹1,200.0026.421,19,7000.08%928−27.96%7,910+29.17%21.14%
Dr Reddy's Labs₹1,390.2041.471,16,1190.58%913−31.35%8,698−1.48%13.04%
Cipla₹1,415.0036.811,14,3160.92%852−35.05%7,404−2.44%15.49%
Shree Ganesh Rem₹605.7564.167780.00%2−67.14%23−23.19%14.16%
Median: 160 Co.₹432.2032.471,9830.08%13+33.73%179+21.23%14.94%

Filings